Shota Inoue

4PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2026
Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma.

|Sep 21, 2026
Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.

|Oct 09, 2025
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlook.

Shota Inoue, Marcin Miszczyk, Agata Suleja

|Sep 13, 2025
Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center Analysis.

Shingo Nishimura, Shota Inoue, Takanori Sekito

Pageof 1

Frequent Collaborators

2 joint publications

Takahiro Kimura

2 joint publications

Tomoaki Yamanoi

2 joint publications

Tatsushi Kawada

2 joint publications

Kensuke Bekku